New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 6, 2012
19:02 EDTABMDAbiomed's Impella retains Class III status by the FDA
Abiomed announced that the FDA Circulatory System Devices Panel voted to retain Class III status for the temporary ventricular support devices within the non-roller type cardiopulmonary bypass blood pumps category, which includes Impella. The 515i Reclassification Panel's confirmation of this category of device as Class III devices is consistent with both the current Class III classification for these device types and as recommended in the FDA's briefing documents, released on December 3.
News For ABMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 24, 2015
16:20 EDTABMDOn The Fly: Closing Wrap
Subscribe for More Information
12:44 EDTABMDOn The Fly: Midday Wrap
Subscribe for More Information
11:04 EDTABMDAbiomed retraces gains, levels to watch
Subscribe for More Information
09:22 EDTABMDOn The Fly: Pre-market Movers
Subscribe for More Information
March 23, 2015
19:13 EDTABMDOn The Fly: After Hours Movers
Subscribe for More Information
17:47 EDTABMDAbiomed confirms FDA approval of Impella 2.5 heart pump
Subscribe for More Information
17:17 EDTABMDFDA approves Impella 2.5 System
The U.S. FDA approved the Impella 2.5 System, a miniature blood pump system intended to help certain patients maintain stable heart function and circulation during certain high-risk percutaneous coronary intervention procedures, such as balloon angioplasty and stenting, which re-open coronary arteries that are narrowed or blocked due to severe coronary artery disease. The Impella 2.5 System is manufactured by Abiomed, based in Danvers, Massachusetts. Reference Link
March 19, 2015
07:17 EDTABMDStephens to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use